Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab

BACKGROUND: Pembrolizumab, an anti-programmed cell death-1 (PD-1) monoclonal antibody, has been shown to yield a durable response and significant survival benefit in some non-small cell lung cancer (NSCLC) patients. Recent studies have shown that the Controlling Nutritional Status (CONUT) score, a n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Ohba, Taro, Takamori, Shinkichi, Toyozawa, Ryo, Nosaki, Kaname, Umeyama, Yasuhiro, Haratake, Naoki, Miura, Naoko, Yamaguchi, Masafumi, Taguchi, Kenichi, Seto, Takashi, Shimokawa, Mototsugu, Takenoyama, Mitsuhiro
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790442/
https://ncbi.nlm.nih.gov/pubmed/31656648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.09.29
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados